These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

438 related items for PubMed ID: 8026285

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Predictors of microalbuminuria in individuals with IDDM. Pittsburgh Epidemiology of Diabetes Complications Study.
    Coonrod BA, Ellis D, Becker DJ, Bunker CH, Kelsey SF, Lloyd CE, Drash AL, Kuller LH, Orchard TJ.
    Diabetes Care; 1993 Oct; 16(10):1376-83. PubMed ID: 8269796
    [Abstract] [Full Text] [Related]

  • 8. Physiological inhibitors of blood coagulation and prothrombin fragment F 1 + 2 in type 2 diabetic patients with normoalbuminuria and incipient nephropathy.
    Mormile A, Veglio M, Gruden G, Girotto M, Rossetto P, D'Este P, Cavallo-Perin P.
    Acta Diabetol; 1996 Sep; 33(3):241-5. PubMed ID: 8904933
    [Abstract] [Full Text] [Related]

  • 9. White coat hypertension in NIDDM patients with and without incipient and overt diabetic nephropathy.
    Nielsen FS, Gaede P, Vedel P, Pedersen O, Parving HH.
    Diabetes Care; 1997 May; 20(5):859-63. PubMed ID: 9135956
    [Abstract] [Full Text] [Related]

  • 10. Albuminuria and 24-h ambulatory blood pressure in normoalbuminuric and microalbuminuric NIDDM patients. A longitudinal study.
    Nielsen S, Schmitz A, Poulsen PL, Hansen KW, Mogensen CE.
    Diabetes Care; 1995 Nov; 18(11):1434-41. PubMed ID: 8722066
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Progression to overt nephropathy in type 2 diabetes: the Casale Monferrato Study.
    Bruno G, Merletti F, Biggeri A, Bargero G, Ferrero S, Pagano G, Cavallo Perin P, Casale Monferrato Study.
    Diabetes Care; 2003 Jul; 26(7):2150-5. PubMed ID: 12832328
    [Abstract] [Full Text] [Related]

  • 16. Raised serum sialic acid concentration in NIDDM patients with and without diabetic nephropathy.
    Chen J, Gall MA, Yokoyama H, Jensen JS, Deckert M, Parving HH.
    Diabetes Care; 1996 Feb; 19(2):130-4. PubMed ID: 8718432
    [Abstract] [Full Text] [Related]

  • 17. The impact of socioeconomic status on cardiovascular risk factors in African-Americans at high risk for type II diabetes. Implications for syndrome X.
    Gaillard TR, Schuster DP, Bossetti BM, Green PA, Osei K.
    Diabetes Care; 1997 May; 20(5):745-52. PubMed ID: 9135936
    [Abstract] [Full Text] [Related]

  • 18. Albuminuria is directly associated with increased plasma PAI-1 and factor VII levels in NIDDM patients.
    Hirano T, Kashiwazaki K, Moritomo Y, Nagano S, Adachi M.
    Diabetes Res Clin Pract; 1997 Apr; 36(1):11-8. PubMed ID: 9187410
    [Abstract] [Full Text] [Related]

  • 19. High prevalence of small LDL particles in non-insulin-dependent diabetic patients with nephropathy.
    Hirano T, Naito H, Kurokawa M, Ebara T, Nagano S, Adachi M, Yoshino G.
    Atherosclerosis; 1996 Jun; 123(1-2):57-72. PubMed ID: 8782837
    [Abstract] [Full Text] [Related]

  • 20. Microalbuminuria among Type 1 and Type 2 diabetic patients of African origin in Dar Es Salaam, Tanzania.
    Lutale JJ, Thordarson H, Abbas ZG, Vetvik K.
    BMC Nephrol; 2007 Jan 15; 8():2. PubMed ID: 17224056
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.